Literature DB >> 11309713

Overview of host defense mechanisms in systemic mycoses and the basis for immunotherapy.

K V Clemons1, D A Stevens.   

Abstract

Host defense against systemic mycoses is multifactoral, depending on innate, as well as acquired, mechanisms. Innate resistance mechanisms include intact physical barriers, host proteins, nonspecific inflammatory responses, hormonal status, sex, and genetic make-up. However, the importance of any 1 factor in resistance to systemic fungal infections can vary depending on the causative agent. Macrophages and neutrophils play a critical role in the stasis or killing of these organisms by using the production of oxygen radicals, cationic proteins, nitric oxide (NO), and peroxides or iron deprivation. Although these cells are often ineffective in killing the organisms innately, activation of macrophages and neutrophils during an acquired immune response by the proinflammatory cytokine interferon-gamma as well as colony-stimulating factors increases the capacity of these cells for killing. A strong Th1 response can provide protective immunity, whereas a Th2 response can result in increased disease severity. The importance of native antibodies in resistance to mycoses remains in question.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309713     DOI: 10.1053/srin.2001.22729

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  13 in total

Review 1.  Epithelial cells and innate antifungal defense.

Authors:  G Weindl; J Wagener; M Schaller
Journal:  J Dent Res       Date:  2010-04-15       Impact factor: 6.116

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

Review 3.  Novel immune regulatory pathways and their role in immune reconstitution syndrome in organ transplant recipients with invasive mycoses.

Authors:  N Singh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

Review 4.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 5.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

6.  Temporal expression of inflammatory mediators in brain basilar artery vasculitis and cerebrospinal fluid of rabbits with coccidioidal meningitis.

Authors:  K E Zucker; P Kamberi; R A Sobel; G Cloud; D N Meli; K V Clemons; D A Stevens; P L Williams; S L Leib
Journal:  Clin Exp Immunol       Date:  2006-03       Impact factor: 4.330

7.  Association of IgG immunoglobulin and subclasses level with the severity of chromoblastomycosis due to Fonsecaea pedrosoi and therapeutic response to itraconazole.

Authors:  C D M P e Silva de Azevedo; O Bruña-Romero; S G Marques; F R F do Nascimento; M C Pinto; L A Silva; L E M Bouillet; F S de Azevedo; M A de Resende Stoianoff
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-15       Impact factor: 3.267

8.  Dectin-1 Fc targeting of aspergillus fumigatus beta-glucans augments innate defense against invasive pulmonary aspergillosis.

Authors:  Polly E Mattila; Allison E Metz; Rekha R Rapaka; Lynne D Bauer; Chad Steele
Journal:  Antimicrob Agents Chemother       Date:  2007-12-17       Impact factor: 5.191

9.  Cellular immune response of patients with chromoblastomycosis undergoing antifungal therapy.

Authors:  Viviane Mazo Fávero Gimenes; Paulo Ricardo Criado; José Eduardo Costa Martins; Sandro Rogério Almeida
Journal:  Mycopathologia       Date:  2006-08       Impact factor: 3.785

10.  The Effects of Opium Addiction on the Immune System Function in Patients with Fungal Infection.

Authors:  Seyyed Amin Ayatollahi-Mousavi; Gholamreza Asadikaram; Nouzar Nakhaee; Alireza Izadi; Nasser Keikha
Journal:  Addict Health       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.